WELLMARKER BIO
Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center. Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developing new drugs that overcome resistance of existing therapeutic approaches. Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer.
WELLMARKER BIO
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2016-12-22
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.wmbio.co
Total Employee:
51+
Status:
Active
Contact:
+82-2-6952-1631
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Content Delivery Network Nginx JsDelivr AJAX Libraries API Korea Telecom Cafe24 DNS
Official Site Inspections
http://www.wmbio.co Semrush global rank: 8.25 M Semrush visits lastest month: 346
- Host name: 183.111.182.232
- IP address: 183.111.182.232
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Wellmarker Bio"
WMBIO
๋ ๊ฑด๊ฐํ ์ธ์์ ์ํ ๋ ธ๋ ฅ. ์ฐ๋ง์ปค๋ฐ์ด์คใ๋ ๋ฏธ์ถฉ์กฑ ์๋ฃ์์ ํด๊ฒฐ์ ์ํด ์น๋ฃ๋ฐ์ ์์ธก ๋ฐ์ด์ค๋ง์ปค(Predictive Biomarker) ๊ธฐ๋ฐ์ ํญ์์ ๋ฅผ ๊ฐ๋ฐํ๊ณ ์์ต๋๋ค. ์์ธ์์ฐ๋ณ์์ โฆSee details»
Wellmarker Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +82-2-6952-1631 Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience โฆSee details»
Wellmarker Bio (WMBIO) - LinkedIn
Wellmarker Bio (WMBIO) | 136 followers on LinkedIn. Develops anticancer drugs based on predictive biomarkers with unmet needs | Wellmarker Bio is a spin-off company from Seoul Asan Medical Center ...See details»
Wellmarker Bio Co., Ltd. (Wellmarker Bio Co., Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
SEOUL, South Korea , Feb. 7, 2023 /PRNewswire/ -- Wellmarker Bio Co., Ltd (WMBIO) (CEO: Dong-Hoon Jin, Department of Convergence Medicine, Ulsan College of Medicine and Asan โฆSee details»
Wellmarker Bio Company Profile | Management and Employees โฆ
Www.wmbio.co Wellmarker Bio Profile and History Wellmarker Bio, the company that specializes in first-in-class anticancer drug development was introduced as an innovative growth company โฆSee details»
Wellmarker Bio signs MoU with Isogenica for the โฆ
May 30, 2022 Wellmarker Bio Co., Ltd (WMBIO), the first company to be spun out from the renowned Asan Medical Center, Koreaโs largest hospital, focuses on the development of novel anticancer drugs derived from comprehensive โฆSee details»
Wellmarkerbio (WMBIO) - VentureRadar
Website: https://wmbio.co. Pioneers the development of anticancer drugs using predictive biomarkers, aiming to optimize treatment responses and address unmet medical needs. ...See details»
WellMarker Bioโdeveloping fit-for-purpose biomarkers and novel ...
WellMarker Bio Co., Ltd www.wmbio.co WellMarker Bioโdeveloping fit-for-purpose biomarkers and novel therapies for cancer Seoul-based WellMarker Bio is developing a deep pipeline of โฆSee details»
Wellmarker Bio - Overview, News & Similar companies - ZoomInfo
Feb 7, 2023 www.wmbio.co. Revenue $6.3 Million. Industry Business Services General Business Services . Recent News & Media. Wellmarker Bio Announces Clinical Trial โฆSee details»
WellMarker Bio-developing fit-for-purpose biomarkers โฆ
WellMarker Bio Co., Ltd (WMBIO), the first company to be spun out from the renowned Asan Medical Center, Koreaโs largest hospital, focuses on the development of new anticancer drugs derived from ...See details»
์ฐ๋ง์ปค๋ฐ์ด์ค - ์ํค๋ฐฑ๊ณผ, ์ฐ๋ฆฌ ๋ชจ๋์ ๋ฐฑ๊ณผ์ฌ์
์ฐ๋ง์ปค๋ฐ์ด์ค(wmbio Co. Ltd.)๋ ์น๋ฃ๋ฐ์ ์์ธก ๋ฐ์ด์ค๋ง์ปค ๊ธฐ๋ฐ ํญ์์ ๊ฐ๋ฐ ์ ๋ฌธ ๋ํ๋ฏผ๊ตญ ๊ธฐ์ ์ผ๋ก ์์ธ์์ฐ๋ณ์์์ ๋ถ์ฌ๋์๋ค [1] ๋ํ์ด์ฌ๋ ๋ํ๊ต์์ด์ ์์ธ์์ฐ๋ณ์ ์ด๋ โฆSee details»
Wellmarker Bio - Craft
Wellmarker Bio (WMBIO) is a company developing anticancer drugs based on predictive biomarkers. It is focused on solid tumors.See details»
WellmarkerBio receives approval for Phase I clinical trial from the ...
SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Wellmarker Bio(www.wmbio.co) announced that on February 23, 2021 the company received approval from the Australian โฆSee details»
Wellmarker Bio Announces Clinical Trial Collaboration with MSD to ...
Feb 7, 2023 Wellmarker Bio Co., Ltd (WMBIO) is the first company to be spun out from the renowned Asan Medical Center, Korea's largest hospital. It focuses on the development of โฆSee details»
WMBIO Trademark of Wellmarker Bio Co., LTD. - Registration โฆ
Pharmaceutical agents affecting sensory organs; vaccines; vitamin preparations; nervines in the nature of pharmaceutical preparations to calm the nerves; digestives for pharmaceutical โฆSee details»
WellmarkerBio receives approval for Phase I clinical trial from the ...
SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods AdministrationSee details»
WellmarkerBio receives approval for Phase I clinical trial from the ...
SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Wellmarker Bio(www.wmbio.co) announced that on February 23, 2021 the company received approval f...See details»
Transforming the future of antibody therapeutics
Actively seeking partners for future co-develop-ment, particularly for clinical development, and for investment. ChongKunDangPharmaceuticalCorp ... (WMBIO), the first company to beSee details»
WM-A1-3389 - Drug Targets, Indications, Patents - Synapse
Once a drug candidate is at that stage, WMBIO would seek to find global pharmaceutical companies to partner with for co-development or licensing. For further information, visit: About โฆSee details»
Meeting Abstract: 2020 ASCO Annual Meeting I - ASCO Publications
May 25, 2020 Background: CTC (Circulating tumor cells) has the advantage of being able to effectively investigate non-invasive diagnosis, prediction, and prognosis for non-surgical โฆSee details»